Molecular basis of heparin-induced thrombocytopenia; new therapeutical perspectives

Abstract

Heparin-induced immune thrombocytopenia is a relatively common and severe complication of heparin treatment, especially of its unfractionated form. It results in a high mortality rate, especially when not diagnosed. This paper covers the molecular basis, clinical picture and treatment methods of heparin-induced immune thrombocytopenia.